FridayJan 04, 2019 12:28 pm

ChineseInvestors.com, Inc. (CIIX) Engages Boustead Securities, LLC for Planned IPO of CBD Biotech

Company has retained Boustead Securities for underwriting of the planned IPO for wholly owned foreign enterprise CBD Biotech CIIX is taking necessary steps to support the growth strategy currently in place for CBD Biotech With the finalized spinoff of CBD Biotech, CIIX will look to refocus on its original mission ChineseInvestors.com, Inc. (OTCQB: CIIX), a leading financial news media and content platform serving the global Chinese-speaking community, recently announced (http://ibn.fm/JRGbs) that it has retained Boustead Securities, LLC for the underwriting of the planned initial public offering (IPO) of its wholly owned foreign enterprise, CBD Biotech Co. Ltd. According to Warren Wang,…

Continue Reading

FridayJan 04, 2019 12:23 pm

QualityStocksNewsBreaks – Spectrum Global Solutions, Inc. (SGSI) Revenues Tracking Over $33M Annually Attributed to Acquisition, Operations

Spectrum Global Solutions (OTC: SGSI), a leading telecommunications engineering and infrastructure services provider, utilizes its growth strategy which includes acquisitions and organic growth through operations. A recent article discussing the company reads, “Spectrum Global Solutions, Inc. (OTC: SGSI), a leading single-source provider of end-to-end, next-generation wireless and wireline network infrastructure and professional service solutions to the service provider (carrier) and corporate enterprise markets, has grown revenues from zero in early 2017 to currently tracking more than $33 million annually, CEO Roger Ponder informed shareholders and investors in a recent 2018 update (http://ibn.fm/4GH7A). … The SGSI revenue growth has come through…

Continue Reading

FridayJan 04, 2019 12:13 pm

QualityStocksNewsBreaks – CytoDyn Inc. (CYDY) Foresees Market Availability of PRO 140 by 2020

Biotechnology company CytoDyn (OTCQB: CYDY) anticipates that it will attain final FDA approval for its HIV treatment, PRO 140, by the fourth quarter of 2019. The company expects market availability will follow by 2020. An article further discussing the company reads, “Leronlimab (PRO 140) is part of a new class of HIV drugs that protects healthy cells from infection by the virus. It’s a humanized IgG4 monoclonal antibody that binds to CCR5, a cellular co-receptor with multiple roles including implications for HIV infection, tumor metastasis and immune signaling. Less frequent dosing, minimal side effects and hardly any toxicity are among…

Continue Reading

FridayJan 04, 2019 12:07 pm

Kontrol Energy Corp.’s (CSE: KNR) (FSE: 1K8) Smart Energy Solutions Could Cut Cannabis Cultivation Costs

Kontrol Energy is entering the cannabis vertical sector, as legalization of recreational cannabis in Canada opens up C$6 billion market Company’s smart energy solutions, utilizing IoT, cloud and SaaS technologies, could significantly cut costs As competition intensifies, production efficiency is set to become a differentiating success factor The legalization of recreational cannabis on October 17, 2018, in Canada has opened a market, estimated at just under C$6 billion, to competitive forces. Now, market pressure will, undoubtedly, drive the search for more efficient production methods. One big-ticket item set to garner attention is the cost of energy, which makes up around…

Continue Reading

FridayJan 04, 2019 11:33 am

Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF) Sees Opportunity in Applying Novel Skin Remedies to Health Concerns

Therma Bright’s thermal, dermatological technologies finding value in responding to array of concerns, from pain to pandemics Wider cosmeceutical industry expected to grow at CAGR of 8.21 percent between 2017 and 2023 Therma Bright’s niche focus is in strengthening skin defenses through non-invasive infrared energy and cannabidiol properties Skin health is a critical component of a person’s overall wellness, and the researchers at Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF) are making dermatological defenses the first line of resistance against a variety of medical concerns ranging from pain to pandemics. The medical device developer has been an innovator in the…

Continue Reading

FridayJan 04, 2019 11:24 am

QualityStocksNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Set to Gain from Exclusive Licensing Agreement for Innovative Spray Technology

ChineseInvestors.com (OTCQB: CIIX), developer of a proprietary financial news media and content platform providing information to the global Chinese-speaking community, recently announced the execution of a letter of intent (“LOI”) to acquire exclusive rights to all sales channels for the VitaMist product line in Asian markets domestically and internationally. A recent article further discussing the company’s deal reads, “ChineseInvestors.com, Inc.’s (OTCQB: CIIX) LOI with BCDBG, Inc. for the global Asian community sales rights to organic VitaMist is not only expected to expand its consumer division; it also calls for development of an exclusive line giving CIIX vitamin spray as well…

Continue Reading

FridayJan 04, 2019 11:12 am

Icon Exploration Inc. (TSX.V: IEX.H) Building Presence in Booming Cannabis Space

Cannabis researchers predict that global sales of the plant will reach $32 billion by 2022 Canada’s recent nationwide legalization of adult uses of cannabis is fueling a spike in labor force opportunities, including a 266 percent increase in cannabis jobs Icon Exploration’s agreement with City View Green (CVG) is sowing the seeds of growth as the Canadian cannabis license applicant prepares a 40,000-square-foot cultivation facility New job and wage statistics released just shy of Canada’s two-month anniversary for full-use cannabis legalization underscore the strength of the ‘weed’ industry, as well as the market potential of companies such as Icon Exploration…

Continue Reading

FridayJan 04, 2019 10:30 am

QualityStocksNewsBreaks – Sugarmade, Inc. (SGMD) Stands Firm in its Commitment to Supply the Legal Cannabis Cultivation Industry

Sugarmade (OTCQB: SGMD) remains focused on supplying equipment and technologies to support the legal cultivation, processing and storage of cannabis and other agricultural products. A recent article discussing the company reads, “Sugarmade is expecting substantial payoff for its commitment to the industry. The company intends to invest in Hempistry, Inc. a privately held Nevada corporation, which has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain in the U.S. State of Kentucky (http://ibn.fm/39SPe). In addition, Sugarmade has signaled strong interest in an agreement with Hempistry for hemp cultivation supplies. Hempistry has already begun planting and has signed an agreement reserving…

Continue Reading

FridayJan 04, 2019 9:59 am

QualityStocksNewsBreaks – Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) Secures Over $2.4M in Initial Cannabis Product Sales in California

Vertically integrated cannabis company Sunniva (CSE: SNN) (OTCQX: SNNVF) this morning announced that it has secured more than USD $2.4 million in future sales of Sunniva branded cannabis products, to be completed in the first four months of 2019. Achieved through one of the company’s existing retail relationships, this marks Sunniva’s first cannabis product sales in the state of California, and it anticipates securing additional sales contracts in the near future. Sunniva’s current product inventory is estimated at a value in excess of USD $5 million and consists of ultrapure cannabis distillate, premium concentrates and flower. The company intends to…

Continue Reading

FridayJan 04, 2019 9:30 am

QualityStocksNewsBreaks – Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Retains Hybrid Financial Ltd. for IR Services

Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) recently announced that it has retained Hybrid Financial Ltd., a marketing and retail distribution services company, to provide certain investor relations (“IR”) services for an initial term of six months. Canopy Rivers will pay Hybrid a monthly fee of CAD $14,000, and has granted Hybrid options to purchase up to 120,000 shares of the company at a price of $3.50 per share. Starting three months after the grant, the options shall vest in quarterly increments and will expire within 12 months of the grant, except for the final tranche, which expires three months following…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered